PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PacBio (NASDAQ: PACB) announced that its management will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, at 9:00 AM ET in Boston, Massachusetts. A live webcast and a replay (available for at least 30 days) will be accessible via the company’s investor website.
Details
News Market Reaction – PACB
On Jul 29, the first trading day after this news, PACB closed 0.72% above the previous close. Our momentum scanner recorded 4 alerts for this stock that day.
Data tracked by StockTitan Argus for the Jul 29 session.
Key Figures
- Conference edition
- 46th
- Canaccord Genuity Annual Growth Conference
- Conference date
- August 11, 2026
- Scheduled management fireside chat
- Event time
- 9:00 AM ET
- Scheduled fireside chat
- Replay availability
- at least 30 days
- Following the webcast
Historical Context
-
Company scheduled its second-quarter 2026 financial-results conference call.
-
SPRQ-Nx chemistry began worldwide shipping with lower sequencing costs.
-
Management announced participation in a Jefferies healthcare conference fireside chat.
-
Blank Bio announced financing and collaboration involving PacBio sequencing datasets.
-
HiFi sequencing study reported genomic findings in subfertility research.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, at 9:00 AM ET in Boston, Massachusetts.
A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
ir@pacb.com
Media:
pr@pacb.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.